CRO

Recipharm buys into Italy with $165M CMO deal

Swedish contract developer Recipharm is looking to expand its share of the European manufacturing market, trading $164.5 million for Italy's Corvette Pharmaceutical Services. Through the deal, Recipharm gets three new plants in the vicinity of Milan, about 265 more employees, and a roster of clients throughout the continent and across Asia. Story